Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Chiasma, Inc.

Home Clinical Trial Sponsors and OrganizationsChiasma, Inc.

Chiasma, Inc.

ACTIVE

460 Totten Pond Rd Ste 530, 马萨诸塞州诺福克县, Massachusetts, United Stateschiasma.comPublic85 employeesEstablished: 2001-01-01

Part of Amryt Pharma Holdings Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

39

34 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2001

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

23

59.0%

Phase 3

5

12.8%

Trial Status Distribution

Active, not recruiting

34

87.2%

Completed

3

7.7%

Unknown

1

2.6%

Withdrawn

1

2.6%

Clinical Trials

Trials sponsored by this organization (39)

Follow-Up Study in Patients that Participated in the Chiasma Study CHACM-01

Active, not recruiting

Jan 202187 participants

A Phase 3 Study (late stage development study), that compares the efficacy and safety of oral octreotide capsules to placebo in acromegaly patients

Active, not recruiting

Jul 201850 participants

A Phase 3 Study (late stage development study), that compares the efficacy and safety of oral octreotide capsules to placebo in acromegaly patients

Active, not recruiting

Jul 201856 participants

A Phase 3 Study (late stage development study), that compares the efficacy and safety of oral octreotide capsules to placebo in acromegaly patients

Active, not recruiting

Jun 201856 participants

A phase 3 study (late stage development study), that compares the efficacy and safety of octreotide capsules to placebo in acromegaly patients

Active, not recruiting

Jan 201850 participants

Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly

Sep 201756 participants

A Phase 3 Study (late stage development study), that compares the efficacy and safety of oral octreotide capsules to placebo in acromegaly patients

Active, not recruiting

Aug 201756 participants

A Phase 3 Study (late stage development study), that compares the efficacy and safety of oral octreotide capsules to placebo in acromegaly patients

Active, not recruiting

Aug 201756 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials39
Approvals
News

Back to Organizations